Key facts
- This page summarizes Nancy Leaming's Form 4 filing for BIOGEN INC. (BIIB).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Jul 2021, 17:29.
Nancy Leaming - 01 Jul 2021 Form 4 Insider Report for BIOGEN INC. (BIIB)
- Reporting relationship
- Director
- Issuer ticker
- BIIB
- Reported as of
- 01 Jul 2021
- Net transaction value
- $0
- Reporting owner signature
- Suzanne Murray, Attorney in Fact for Nancy Leaming
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Nancy Leaming filed Form 4 for BIOGEN INC. (BIIB) on 02 Jul 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIIB
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +775
- Change %
- +6%
- Price
- $0.000000
- Shares after
- 13,763
- Date
- 01 Jul 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.